England: NICE Finds Its Advice Can Cut Drug Appraisal Times By Three Months

 
• By Neena Brizmohun
  
General stock - UK pounds and prescription drugs
NICE examines the cost-effectiveness of drugs for use in England (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Health Technology Assessment

More from Pink Sheet